What is Asclera for Veins?

This is a drug for injecting into venous tissue, like leg veins, and like all vein treatment, there can be some shadowing when the vein closes.

Asclera is the newest agent for sclerotherapy. It is Polidocanol, which has been in use for a long time, but just recently gained FDA approval. The shadowed side effect is usually from an unskilled surgeon...

Greetings Alison~ Asclera (Polidocanol) is a sclerotherapy solution that has been used in Europe for many years but has only recently been approved by the FDA for treatment in the US. It essentially irritates the lining of the vessels causing them to become ineffective and collapse. Unfortunately, as with the other sclerotherapy agents/solutions, you still run the risk of hemosiderin staining (that shadowing effect you asked about). Having used Asclera in our... more

Fda approved sclerosant agent for small and medium sized spider veins. it is polidocanol and has been used in europe for years.

The long awaited FDA approval for Asclero (Polidocanol) finally  was effectuated  March 30 this year. It seems to me that there have been rumors that this sclerosing agent would be approved for the last thirty years. Sure  Polidocanol  has been used in a number of countries, especially Europe, for years, but technically it was illegal to use in the United States, Unlike many drugs which are used off label, polidocanol had  no FDA indication, and therefore was... more

This is an agent which has been available all over the world and is used to shut down prominent veins. It is essentially a chemical (detergent) which sclerosis irritates the lining of the vein when injected which causes them to clot and subsequently occlude. It is very popular in other parts of the world and has a relatively high safety profile when used properly in the hands of an experienced injector. It was recently approved by the FDA for treating lower extremity veins but it is... more